Skip to main content
R

Rosepetal

Rosepetal provides AI and computer vision solutions for quality control in industrial settings. Their technology optimizes manufacturing processes by detecting defects and inconsistencies, leading to increased efficiency and reduced waste.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

In manufacturing, manual quality control processes are often slow, inconsistent, and prone to human error, leading to inefficiencies and increased waste. Traditional methods struggle to keep pace with high-speed production lines and fail to detect subtle defects that can compromise product integrity.

Solution

Rosepetal provides an AI-powered computer vision software suite designed to automate and optimize quality control processes in industrial settings. The platform uses deep learning and convolutional neural networks to classify products, localize components, count objects, detect anomalies, and perform optical character recognition. Rosepetal's solution integrates with existing camera systems and offers a user-friendly interface for neural network training, including a no-code option for customization. By automating visual inspections, Rosepetal enables manufacturers to identify defects early in the production cycle, reduce manual inspection times, and ensure compliance with industry regulations.

Target Audience

Rosepetal targets manufacturers in the food, pharmaceutical, automotive, electronics, and consumer products industries seeking to automate quality control, reduce waste, and improve production efficiency.

Features

  • AI-powered defect detection in packaging and produce
  • Object counting and classification
  • Component localization and segmentation
  • Anomaly detection in products and packaging
  • Optical character recognition and datamatrix validation
  • User-friendly UI and cloud platform for neural network training
  • No-code option to customize image preprocessing, prediction, and logical post-processing
  • Integration with devices and applications through connectors and API
  • Compliant with FDA 21 CFR Part 11 for pharmaceutical applications
This profile is AI-generated and may contain inaccuracies.